• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Neurocrine Biosciences, Inc. - Common Stock (NQ:NBIX)

    141.81 +0.86 (+0.61%)
    Streaming Delayed Price Updated: 1:12 PM EST, Dec 31, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 300,158
    Open 140.63
    Bid (Size) 141.75 (200)
    Ask (Size) 141.85 (100)
    Prev. Close 140.95
    Today's Range 140.50 - 142.22
    52wk Range 84.23 - 160.18
    Shares Outstanding 99,700,000
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Neurocrine Biosciences Inc (NASDAQ:NBIX) Offers a Prime Example of Growth at a Reasonable Price ↗
    Neurocrine Biosciences exemplifies GARP investing, blending strong earnings growth, solid profitability, and a reasonable stock price within its sector. 
    Via Chartmill
    News headline image
    Neurocrine Biosciences Inc (NASDAQ:NBIX) Combines Strong Fundamentals with Bullish Technical Setup ↗
    Neurocrine Biosciences (NBIX) combines strong growth, high profitability, and a positive technical breakout setup in the neuroscience sector. 
    Via Chartmill

    Performance

    YTD
    +2.9%
    +2.9%
    1 Month
    -6.1%
    -6.1%
    3 Month
    +1.0%
    +1.0%
    6 Month
    +10.8%
    +10.8%
    1 Year
    +3.5%
    +3.5%

    More News

    Read More
    News headline image
    Up 44% Since IPO: Why a Major Fund Just Made a $45 Million Bet on This Digital Health Stock ↗
    Via The Motley Fool
    Topics Initial Public Offering Regulatory Compliance
    News headline image
    Acadia Stock Up 59% in a Year — Is a $51 Million New Stake a Bet on a Bigger Rebound? ↗
    Via The Motley Fool
    News headline image
    Earnings Scheduled For October 28, 2025 ↗
    Via Benzinga
    News headline image
    Soleno Turns First Profit on $66 Million in Revenue — Is This Why One Investor Just Made an $87 Million Bet? ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Neurocrine (NBIX) Q3 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Medicare Slashes Ozempic's Price Tag 71%; Why Novo Nordisk Rallied ↗
    Via Investor's Business Daily
    Topics Economy Government
    News headline image
    This Fund Sold $30 Million in PTC Therapeutics Shares Amid a 93% Rally: Here’s Why ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Why This Fund Trimmed a $161 Million Travere Position After a 100% Rally ↗
    Via The Motley Fool
    News headline image
    High Growth Momentum Stock NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) Shows Strong Earnings Acceleration ↗
    Via Chartmill
    News headline image
    Neurocrine's Depression Drug Fails Phase 2 Goal But Shows Encouraging Safety Profile ↗
    Via Benzinga
    News headline image
    Zoom To Rally Around 38%? Here Are 10 Top Analyst Forecasts For Tuesday ↗
    Via Benzinga
    News headline image
    Neurocrine Biosciences Inc (NASDAQ:NBIX) Fits the Affordable Growth Profile ↗
    Via Chartmill
    News headline image
    Neurocrine Biosciences Inc (NASDAQ:NBIX) Presents a Compelling Value Investment Case ↗
    Via Chartmill
    News headline image
    NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) Q3 2025 Earnings Top Estimates, Driving Stock Momentum ↗
    Via Chartmill
    News headline image
    Neurocrine Bio Surges After Crushing Third-Quarter Expectations ↗
    Via Investor's Business Daily
    News headline image
    Examining the Future: Neurocrine Biosciences's Earnings Outlook ↗
    Via Benzinga
    News headline image
    S&P 500 Tops 6,900 Ahead Fed Rate Move, Gold Reclaims $4,000: What's Moving Markets Wednesday? ↗
    Via Benzinga
    Topics Economy Stocks
    News headline image
    What 13 Analyst Ratings Have To Say About Neurocrine Biosciences ↗
    Via Benzinga
    News headline image
    Demystifying Neurocrine Biosciences: Insights From 12 Analyst Reviews ↗
    Via Benzinga
    News headline image
    Neurocrine Biosciences Inc (NASDAQ:NBIX) Presents an Affordable Growth Opportunity ↗
    Via Chartmill
    News headline image
    NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) Presents a Compelling Growth and Breakout Opportunity ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Neurocrine Biosciences Inc (NASDAQ:NBIX): An Affordable Growth Candidate in Biotechnology ↗
    Via Chartmill

    Frequently Asked Questions

    Is Neurocrine Biosciences, Inc. - Common Stock publicly traded?
    Yes, Neurocrine Biosciences, Inc. - Common Stock is publicly traded.
    What exchange does Neurocrine Biosciences, Inc. - Common Stock trade on?
    Neurocrine Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Neurocrine Biosciences, Inc. - Common Stock?
    The ticker symbol for Neurocrine Biosciences, Inc. - Common Stock is NBIX on the Nasdaq Stock Market
    What is the current price of Neurocrine Biosciences, Inc. - Common Stock?
    The current price of Neurocrine Biosciences, Inc. - Common Stock is 141.81
    When was Neurocrine Biosciences, Inc. - Common Stock last traded?
    The last trade of Neurocrine Biosciences, Inc. - Common Stock was at 12/31/25 01:12 PM ET
    What is the market capitalization of Neurocrine Biosciences, Inc. - Common Stock?
    The market capitalization of Neurocrine Biosciences, Inc. - Common Stock is 14.14B
    How many shares of Neurocrine Biosciences, Inc. - Common Stock are outstanding?
    Neurocrine Biosciences, Inc. - Common Stock has 14B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.